Postoperative management of local colorectal cancer: therapy and surveillance.

Publication/Presentation Date

7-1-2000

Abstract

Adjuvant therapy is widely recommended for stage III colon cancer and stages II and III rectal cancer. Although fluorouracil-based regimens are standard, newer agents either alone or in combination may improve response rates. Although nearly all patients enter a postoperative surveillance program after surgical resection, the clinical effectiveness of such surveillance, which is not standardized, is questionable. Critical review of the use of different components (laboratory, radiographic, and endoscopic) of these programs finds little support for intensive surveillance.

Volume

11

Issue

3

First Page

152

Last Page

156

ISSN

1049-5118

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

10950462

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS